May 29, 2024 – Dr. Marco Infante has been granted with the Extraordinary Ability O1 Visa by the U.S. Citizenship and Immigration Services (USCIS) for Extraordinary Ability in the Sciences.

Read More »

October 10, 2024 – Dr. Marco Infante lecture at the 49th Congress of the International Society for the History of Medicine (Salerno, Italy) – “From Aretaeus of Cappadocia to the bioartificial pancreas: retracing the key events in the history of diabetes mellitus”

Read More »

August 9, 2023 – Dr. Marco Infante has been elected a Full Member of the Sigma Xi Scientific Research Honor Society in recognition of his significant scientific contributions to the field of diabetes mellitus.

Read More »

May 10, 2020 – Dr. Infante has been appointed Distinguished Supervisor for the international Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) of the Universal Scientific Education and Research Network (USERN).

Read More »

Healio News (June 3, 2020): “Long-term data lacking for Hydroxychloroquine use in Type 2 Diabetes, COVID-19”

Read More »

May 27, 2020: Considerations for Hydroxychloroquine Use in Patients with Diabetes Mellitus

Read More »

Type 1 diabetes and technological advances: towards the Artificial Pancreas

Read More »

Dr. Infante’s contribution to the “Europe and Food Report” by the Barilla Center for Food & Nutrition (BCFN) 2021 – “Towards a Sustainable Prevention of Type 2 Diabetes”

Read More »

Dr. Infante’s article “Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic” listed among the Top Cited Articles 2020-2021 in Journal of Diabetes (Wiley)

Read More »

Artificial Organs (Wiley) journal dedicates the September 2021 Issue Cover to Dr. Infante’s article entitled “Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions” [Artif Organs. 2021 Sep;45(9):968-986]

Read More »

Proposed criteria for a cost-effective vitamin B12 deficiency screening in metformin-treated patients – Criteria published by Dr. Marco Infante in World Journal of Diabetes [World J Diabetes. 2021 Jul 15;12(7):916-931]

Read More »

“Medicina” (MDPI) journal dedicates the May 2022 Issue Cover to Dr. Infante’s article entitled “Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents”

Read More »

“An unusual case of Autoantibody-Negative Ketosis-Prone Diabetes (KPD) secondary to marked insulin resistance”: Poster presented by Dr. Infante at The American Diabetes Association Meeting 2022 (ADA’s 82nd Scientific Sessions, 3-7 June 2022, New Orleans, Louisiana, LA, USA)

Read More »

Interview for Giddy: “Eat Like You Want to Live to 100 Years Old – Experts tell us that nutritional tweaks can boost longevity and improve your quality of life.”

Read More »

December 7, 2022 – New Book Release: “Evolving Concepts in Insulin Resistance” – Academic Editor: Marco Infante (IntechOpen – December 2022)

Read More »

June 27, 2023 – Parliamentary Audition at the Defence Committee (Fourth Committee) of the Chamber of Deputies of the Italian Parliament – Project “Healthy Soldier”

Read More »